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A 78-year-old female with a past medical history of mild 
dementia, hypertension, diabetes, coronary artery disease status 
post automatic implantable cardioverter defibrillator (AICD) 
for congestive heart failure presented with suspected bacterial 
endocarditis and AICD lead infection from an outside hospital 
(OSH). The patient initially presented to the OSH with chest 
wall tenderness, fevers up to 101° F, chills, decreased appetite, 
weakness and weight loss. She was diagnosed with a non-ST 
segment myocardial infarction based on elevated troponin levels 
without electrocardiogram changes. At the OSH, blood acid 
fast bacillus (AFB) cultures were checked after routine blood 
cultures and fungal cultures were negative. Three separate blood 
cultures grew out Mycobacterium fortuitum over 3 different time 
intervals at the OSH. The patient was started on trimethoprim/
sulfamethoxazole 160mg/800mg orally three times a day and 
ciprofloxacin 500 mg orally twice a day. It was decided that 
definitive treatment for her persistent bacteremia and suspected 
endocarditis would require removal of the device and leads. The 
patient was transferred to Thomas Jefferson University Hospital 
(TJUH) for AICD lead removal and temporary pacemaker 
placement.  
On admission to TJUH, the patient was afebrile with a normal 
heart and respiratory rate and a blood pressure of 102/78 mm 
Hg. She was awake and alert, but oriented only to person and 
place due to mild underlying dementia. Cardiac exam did 
not reveal any murmurs, rubs, or gallops, but the patient did 
have mild tenderness upon palpation of the pacer pocket site. 
There was no overlying erythema or exudates from the site. Her 
pulmonary, abdominal, and musculoskeletal exams were all 
grossly normal.
Initial laboratory values revealed a white blood cell count of 
4.4/μL. A basic metabolic panel revealed a mildly elevated 
creatinine of 1.6 mg/d with no other major abnormalities. 
Troponins were negative at the time of admission.
Blood cultures for AFB were again positive upon admission 
to TJUH, and intravenous (IV) amikacin and imepenem 
were initiated. The patient then underwent removal of the 
AICD leads. An echocardiogram was done at this time which 
revealed a 0.8 cm heterogenous mass on the aortic side of the 
left coronary cusp consistent with vegetation versus complex 
fibroelastoma, and a 0.8 cm mobile echodensity on the tricuspid 
valve consistent with vegetation.
After removal of her AICD, her blood cultures cleared, but the 
patient remained hospitalized for 4 weeks given the need for 
IV antibiotics and temporary pacing prior to reimplantation of 
her AICD. An AICD was reimplanted one month later without 
complications. The patient was then transferred to a skilled 
nursing facility to continue IV antibiotics for an additional 
month.
Discussion
There are currently approximately 3 million people with 
pacemakers implanted worldwide. Despite obvious benefits 
conferred by these devices, infection of the leads and device and 
subsequent endocarditis remains a common complication. The 
incidence of device related infections has more than doubled 
since 1990, the majority of which are caused by Staphylococcus 
and Streptococcus species. Rapidly Growing Mycobacterium 
(RGM), so called because they grow in 3-4 days as compared to 
other mycobacteria which can takes weeks to grow on culture 
media, are a rare cause of pacemaker infections that carry 
significant morbidity and mortality. The most common of these, 
Mycobacterium fortuitum, is ubiquitous in the environment 
and has been isolated from fresh water, salt water, soil, and in 
hospitals. This RGM can grow in water systems and distilled 
water, and is resistant to sterilizers, antiseptics, and other 
standard disinfectants. The spectrum of disease caused by M. 
fortuitum ranges from surgical wound infections and dermal 
abscesses to osteomyelitis, septic arthritis, pericarditis, and device 
infections. Of note, pulmonary disease caused by M. fortuitum 
infection is rare except in patients with esophageal achalasia, 
lipoid pneumonia, or other diseases characterized by chronic 
vomiting and aspiration. A review of the literature reveals that 
the most common presenting complaints of device infections 
with M. fortuitum include wound discharge, fever, and pain at 
the generator site. Mycobacteria in gram stained specimens may 
appear as refractile, gram positive or gram neutral bacilli, and 
misidentification as Nocardia spp. is common. 
Although previously rare, M. fortuitum device infection rate 
has been on the rise, with over 50% of the cases arising since 
2007. Such infections commonly arise within the first 6 months 
of device implantation, thus suggesting a nosocomial source. 
RGM outbreaks have previously been traced to contaminated 
tap water used to make cardioplegia solution or contaminated 
aqueous solutions used to mark incision sites. As with all device 
infections, definitive treatment involves removal of the device 
and treatment with antibiotics for 4-6 weeks. According to the 
American Thoracic Society Guidelines, M. fortuitum isolates 
are usually susceptible to multiple oral antimicrobial agents, 
including macrolides, quinolones, doxycycline, sulfonamides, 
and beta-lactam antibiotics including imipenem. Although 
specific antibiotic choice depends on susceptibility testing, 
combination therapy is usually preferred to monotherapy. 
Empiric therapy with clarithromycin and a fluoroquinolone is 
a reasonable first step, although mounting evidence suggests 
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increasing resistance to macrolides. In some case series linezolid 
has been used additionally in the first 2 weeks of treatment. 
Our patient’s course was complicated by need for multiple 
antibiotic regimens. The patient failed the initial regimen of 
trimethoprim/sulfamethoxazole and ciprofloxacin, and was 
subsequently started on imipenem and amikacin. However, 
the patient developed thrombocytopenia as a side effect of 
imipenem. Final regimen on discharge included tigecycline, 
amikacin, and trimethoprim/sulfamethoxazole.
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